FIELD: medicine.
SUBSTANCE: what is presented is a method for acute exposure to organophosphates with pronounced non-anticholinesterase mode of toxicity. A method consists in preventive administration of β-oestradiol 100 mg/kg 20-60 min prior to application of the toxic agent organophosphate.
EFFECT: reducing the manifestations of first signs of the exposure, developing convulsions and complete elimination of animals' death experimentally, administering β-oestradiol 5 days or 1 day before the exposure has not been producing such an effect.
3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION WITH ANTICONVULSANT ACTIVITY FOR PARENTERAL INTRODUCTION | 2011 |
|
RU2463052C1 |
| (1-METHYLPIPERIDIN-4-YL)-2-PROPYL PENTANOATE HYDROCHLORIDE, HAVING CHOLINOLYTIC AND ANTICONVULSANT ACTIVITY | 2019 |
|
RU2714135C1 |
| THERAPEUTIC PREPARATION AT SPASMODIC SYNDROME | 2001 |
|
RU2191017C1 |
| MIXED COBALT (II) SALTS OF KETOCARBOXYLIC AND MERCAPTOCARBOXYLIC ACIDS AND HYDRATES THEREOF, OR SOLVATES THEREOF, METHODS FOR PRODUCTION AND USE THEREOF AS CYANIDE ANTIDOTES | 2013 |
|
RU2553275C2 |
| 2-BENZOYLAMINOMETHYLBENZIMIDAZOLE HYDROCHLORIDE SHOWING ANTISPASMODIC, ANTIHYPOXIC AND ANTITOXIC EFFECTS AT DIFFERENT CONVULSIVE AGENTS EFFECT | 1994 |
|
RU2109737C1 |
| COMPOSITION FOR TREATING SPASMODIC SYNDROME CASES | 2006 |
|
RU2314829C1 |
| 3-METHYL-1,2,4-TRIAZOLE-5-THIOACETATE (S) -2,6-DIAMINOHEXANE ACID APPLICATION AS ACTIVE DRUG BASE FOR PREVENTION AND TREATMENT OF CNS VITAL FUNCTIONS IN CASE OF SEVERE FORMS OF ACUTE ETHANOL POISONING | 2016 |
|
RU2613875C1 |
| METHOD FOR REDUCING ISONIAZID NEUROTOXICITY EXPERIMENTALLY | 2014 |
|
RU2574027C1 |
| AGENT EXHIBITING HEPATOPROTECTIVE, LIPID-REGULATING, ANTIISCHEMIC AND NEUROTROPIC ACTIVITY | 2018 |
|
RU2705575C1 |
| MEANS FOR TREATING SPASMODIC SYNDROME CASES | 2006 |
|
RU2314828C1 |
